Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for percutaneous vessel closure. Vivasure’s device is designed ...

The company plans to launch the lens, which supports vision at all distances, in Europe in the coming weeks.

"Securing CE Mark approval for PerQseal Elite marks a major milestone for Vivasure and for patients undergoing complex structural heart procedures," said Andrew Glass, CEO of Vivasure Medical.

Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer (NSCLC) simultaneously with immune checkpoint inhibitors or docetaxel.

Optune Lua received a CE Mark for treating metastatic NSCLC ... Optune Lua, as explained in the news release, is a wearable medical device that delivers Tumor Treating Fields (TTFields), a means of ...

The award of the Class 1 CE mark means that the apps have met safety and performance requirements for medical devices in the UK and EU – and comes just two years after Vinehealth was founded to ...

Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer (NSCLC) simultaneously with immune checkpoint inhibitors or docetaxel. This ...

Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for percutaneous vessel closure. Vivasure’s device is designed for ...